Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of MDMA-assisted psychotherapy for PTSD, including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials.

(00:00:00) Introduction

(00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial.

(00:14:58) Challenges in supporting participants in psychedelic studies after the end of the trial.

(00:23:11) Standardizing therapy for MDMA-assisted therapy trial.

(00:32:11) The importance of non-directional support.

(00:36:37) Operationalizing therapy techniques to ensure consistency and address power imbalances.

(00:43:06) Psychedelic therapy adherence and rating systems.

(00:50:08) Therapist flexibility in the trial.

(00:59:41) Inclusion of diverse participants.

Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/

Integrata: www.integratahealing.com

Dr. Ingmar Gorman: https://www.ingmargorman.com/about

Lykos: https://lykospbc.com